
The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if patients report them early.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sCoqRF
via
IFTTT
0 comments:
Post a Comment